CoChat

La melatonina reduce la respuesta de cortisol al ACTH en humanos

Open access
Campino, Carmen, Valenzuela, Francisco, Arteaga, Eugenio, Torres-Farfán, Claudia, Trucco, Cristián, Velasco, Alfredo, Guzmán, Sergio, Serón-Ferré, María · 2008 · Revista medica de Chile

The DOI matches its Crossref record; 35 of the 38 references it cites were found in a registry or an index; none of the 33 sources its claims cite is checked for support yet.

Abstract

BACKGROUND: Melatonin receptors are widely distributed in human tissues but they have not been reported in human adrenal gland. AIM: To assess if the human adrenal gland expresses melatonin receptors and if melatonin affects cortisol response to ACTH in dexamethasone suppressed volunteers. MATERIAL AND METHODS: Adrenal glands were obtained from 4 patients undergoing unilateral nephrectomy-adrenalectomy for renal cancer. Expression of mRNA MT1 and MT2 melatonin receptors was measured by Reverse TranscriPtase Polymerase Chain Reaction (RT-PCR). The effect of melatonin on the response to intravenous (i.v.) ACTH was tested (randomized cross-over, double-blind, placebo-controlled trial) in eight young healthy males pretreated with dexamethasone (1 mg) at 23:00 h. On the next day, at 08:00 h, an i.v. line was inserted, at 08:30 h, and after a blood sample, subjects ingested 6 mg melatonin or placebo. At 09:00 h, 1-24 ACTH (Cortrosyn, 1 microg/1.73 m2 body surface area) was injected, drawing samples at 0, 15, 30, 45 and 60 minutes after. Melatonin, cortisol, cortisone, progesterone, aldosterone, DHEA-S, testosterone and prolactin were measured by immunoassay. RESULTS: The four adrenal glands expressed only MT1 receptor mRNA. Melatonin ingestion reduced the cortisol response to ACTH from 14.6 +/- 1.45 microg/dl at 60 min in the placebo group to 10.8 +/- 1.2 microg/dl in the melatonin group (p < 0.01 mixed model test). It did not affect other steroid hormone levels and abolished the morning physiological decline of prolactin. CONCLUSIONS: The expression of MT1 melatonin receptor in the human adrenal, and the melatonin reduction of ACTH-stimulated cortisol production suggest a direct melatonin action on the adrenal gland.

Overview

CoChat Summary

TL;DR

In dexamethasone-suppressed healthy young men, a single 6 mg oral dose of melatonin reduced the cortisol response to ACTH, and human adrenal tissue expressed MT1 but not MT2 melatonin receptor mRNA. Melatonin also prevented the morning decline in prolactin without significantly affecting other measured adrenal steroids.

Key findings

  • Human adrenal glands from 4 patients expressed only MT1 receptor mRNA; MT2 mRNA was not detected in adrenal tissue, whereas the renal positive control expressed both MT1 and MT2. The MT1 PCR product matched bases 477–912 of human MT1 mRNA.
  • In 8 dexamethasone-suppressed healthy males, melatonin reduced ACTH-stimulated cortisol: 14.6 ± 1.45 µg/dl at 60 min with placebo vs 10.8 ± 1.2 µg/dl with melatonin (p < 0.01 mixed model in the abstract; results report lower values at 45 and 60 min, p < 0.05 mixed models). The effect was observed in 7 of 8 subjects.
  • Melatonin did not significantly affect cortisone, progesterone, aldosterone, DHEA-S, or testosterone responses to ACTH. It abolished the morning physiological decline of prolactin, with higher prolactin than placebo from 30 to 60 min post-ACTH (p < 0.01 mixed models).
  • Plasma melatonin rose after 6 mg and remained elevated throughout the ACTH test (e.g., 10,778.1 ± 2,210.1 pg/ml at +30 min vs 52.1 ± 3.7 pg/ml with placebo).

Methods

  • Adrenal tissue was obtained from 4 patients undergoing unilateral nephrectomy-adrenalectomy for renal cancer; MT1 and MT2 melatonin receptor mRNA expression was measured by RT-PCR, and the MT1 product was sequenced.
  • The acute effect of melatonin on ACTH-stimulated steroidogenesis was tested in a randomized, double-blind, placebo-controlled crossover trial in 8 clinically healthy, non-obese males aged 24–34 years (BMI 24.8 ± 0.75 kg/m²). Subjects received dexamethasone 1 mg at 23:00 h, then 6 mg melatonin or placebo at 08:30 h, followed by 1-24 ACTH (1 µg/1.73 m² body surface area, i.v.) at 09:00 h; blood was sampled at 0, 15, 30, 45, and 60 min.
  • Hormones were measured by immunoassay. Time courses were analyzed by one-way repeated-measures ANOVA with Tukey tests, and placebo vs melatonin comparisons used mixed models (SAS); significance was set at p < 0.05.

Limitations

  • The authors state that the experimental design does not allow establishing whether the in vivo reduction in cortisol response to ACTH was due to direct actions on the adrenal gland, although adrenal MT1 expression opens that possibility.
  • The authors note that differences from prior in vitro primate adrenal studies may be due to protocol duration, since in vitro exposure to ACTH and melatonin was 48 h.
  • Evident from the text: the study used very small samples (4 adrenal glands and 8 male volunteers) and included only young healthy men, limiting generalizability to women, older adults, or clinical populations.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.4067/s0034-98872008001100004

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figura 1. Expresión del mARN de los receptores MT1 y MT2 de melatonina y de 18S-rARN en glándula suprarrenal humana y en tejido renal analizado por RT-PCR. Línea 1: Adenoma suprarrenal. Carriles: 2, 3, 4: Glándulas suprarrenales normales. En las muestras de tejido suprarrenal, los productos de PCR para los receptores MT1 y MT2 de melatonina se obtuvieron a partir de concentraciones de cADN equivalentes a 300 ng de ARN y para 18S-rARN a 150 ng de ARN. En el tejido renal, los productos de PCR para los receptores MT1 y MT2 de melatonina y para 18SrARN se obtuvieron a partir de concentraciones de cADN equivalentes a 150 ng de ARN.
Figura 1. Expresión del mARN de los receptores MT1 y MT2 de melatonina y de 18S-rARN en glándula suprarrenal humana y en tejido renal analizado por RT-PCR. Línea 1: Adenoma suprarrenal. Carriles: 2, 3, 4: Glándulas suprarrenales normales. En las muestras de tejido suprarrenal, los productos de PCR para los receptores MT1 y MT2 de melatonina se obtuvieron a partir de concentraciones de cADN equivalentes a 300 ng de ARN y para 18S-rARN a 150 ng de ARN. En el tejido renal, los productos de PCR para los receptores MT1 y MT2 de melatonina y para 18SrARN se obtuvieron a partir de concentraciones de cADN equivalentes a 150 ng de ARN.From the PDF
Figura 2. Efecto de melatonina sobre la concentración plasmática de cortisol ( x ± EE, n =8) en respuesta a 1-24 ACTH (1 µ g/1,73 m 2 de superficie corporal, i.v.) en sujetos suprimidos con dexametasona. Placebo (círculos vacíos) o una dosis única de melatonina (6 mg, círculos llenos) fueron ingeridos al tiempo que indica la pequeña flecha blanca. * Diferente a ACTH con melatonina (P <0,01, análisis de modelos mixtos).
Figura 2. Efecto de melatonina sobre la concentración plasmática de cortisol ( x ± EE, n =8) en respuesta a 1-24 ACTH (1 µ g/1,73 m 2 de superficie corporal, i.v.) en sujetos suprimidos con dexametasona. Placebo (círculos vacíos) o una dosis única de melatonina (6 mg, círculos llenos) fueron ingeridos al tiempo que indica la pequeña flecha blanca. * Diferente a ACTH con melatonina (P <0,01, análisis de modelos mixtos).From the PDF
Image 3
From the PDF

Verification

Claims the paper makes

0 Valid · 0 Not valid · 14 Not checked · 18 Own results and interpretations

8 more claims

Create a free account to see all 32 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 12
  • It may state two separate claims as one. 12

Create a free account to see these claims.

Citations

Cites

Show all 35 references

Cited by

See all 23

Metadata

Authors
Campino, C., Valenzuela, F., Arteaga, E., Torres-Farfán, C., Trucco, C., Velasco, A., Guzmán, S., & Serón-Ferré, M.
Affiliations
  • Pontificia Universidad Católica de Chile (CL)
  • University of Chile (CL)
Venue
Revista medica de Chile
Published
2008-11
Volume
136
Issue
11
Pages
1390-7
ISSN
0034-9887 (ISSN-L)
OpenAlex
W2136849615
Cited by
23
References
38
Citations by year
2026: 2 · 2025: 3 · 2023: 3 · 2022: 1 · 2020: 2 · 2018: 2 · 2016: 2 · 2015: 1 · 2013: 2 · 2012: 1
FWCI
0.59
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Revista médica de Chile (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, cc-by)
  • Universidad de Chile (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
melatonin, melatonin receptors, MT1 receptor, adrenal gland, ACTH stimulation test, cortisol, dexamethasone suppression, adrenal steroidogenesis, prolactin
MeSH terms
Adrenal Glands, Adrenocorticotropic Hormone, Adult, Dexamethasone, Double-Blind Method, Glucocorticoids, Humans, Hydrocortisone, Immunoassay, Male, Melatonin, RNA, Messenger, Time Factors, Cross-Over Studies, Reverse Transcriptase Polymerase Chain Reaction, Receptor, Melatonin, MT1, Receptor, Melatonin, MT2, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: La melatonina reduce la respuesta de cortisol al ACTH en humanos. https://app.cochat.ai/papers/10.4067/s0034-98872008001100004
The paper
Campino, C., Valenzuela, F., Arteaga, E., Torres-Farfán, C., Trucco, C., Velasco, A., Guzmán, S., & Serón-Ferré, M. (2008). La melatonina reduce la respuesta de cortisol al ACTH en humanos. Revista medica de Chile. https://doi.org/10.4067/s0034-98872008001100004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.